IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $78,052,000 | +164.1% | 917,939 | +10.1% | 0.02% | +137.5% |
| Q2 2020 | $29,557,000 | +151.1% | 833,984 | -4.5% | 0.01% | +100.0% |
| Q1 2020 | $11,770,000 | -34.7% | 873,148 | +2.6% | 0.00% | -20.0% |
| Q4 2019 | $18,011,000 | +63.5% | 851,108 | +2.5% | 0.01% | +66.7% |
| Q3 2019 | $11,013,000 | -5.9% | 830,520 | -1.5% | 0.00% | 0.0% |
| Q2 2019 | $11,699,000 | -17.9% | 843,554 | +13.7% | 0.00% | -25.0% |
| Q1 2019 | $14,255,000 | +42.3% | 742,020 | +5.7% | 0.00% | +33.3% |
| Q4 2018 | $10,021,000 | -31.6% | 702,209 | -0.1% | 0.00% | -25.0% |
| Q3 2018 | $14,643,000 | -12.3% | 702,956 | -0.4% | 0.00% | -20.0% |
| Q2 2018 | $16,705,000 | +90.3% | 705,730 | +17.4% | 0.01% | +150.0% |
| Q1 2018 | $8,780,000 | -5.9% | 600,988 | +4.1% | 0.00% | 0.0% |
| Q4 2017 | $9,332,000 | -2.0% | 577,459 | -15.3% | 0.00% | -33.3% |
| Q3 2017 | $9,527,000 | +71.8% | 681,419 | +8.5% | 0.00% | +50.0% |
| Q2 2017 | $5,546,000 | +84.7% | 628,135 | +35.3% | 0.00% | +100.0% |
| Q1 2017 | $3,003,000 | +85.7% | 464,215 | +5.3% | 0.00% | – |
| Q4 2016 | $1,617,000 | +21.8% | 440,697 | +7.8% | 0.00% | – |
| Q3 2016 | $1,328,000 | +32.7% | 408,664 | -5.3% | 0.00% | – |
| Q2 2016 | $1,001,000 | -4.9% | 431,506 | +2.4% | 0.00% | – |
| Q1 2016 | $1,053,000 | -23.0% | 421,401 | -5.4% | 0.00% | – |
| Q4 2015 | $1,368,000 | +85.1% | 445,497 | +3.8% | 0.00% | – |
| Q3 2015 | $739,000 | -67.6% | 429,299 | -23.6% | 0.00% | -100.0% |
| Q2 2015 | $2,281,000 | +13.0% | 561,875 | +6.6% | 0.00% | 0.0% |
| Q1 2015 | $2,018,000 | -5.9% | 526,857 | +17.9% | 0.00% | 0.0% |
| Q4 2014 | $2,145,000 | +34.2% | 446,810 | +4.0% | 0.00% | – |
| Q3 2014 | $1,598,000 | -43.4% | 429,618 | -44.5% | 0.00% | – |
| Q2 2014 | $2,824,000 | +80.8% | 773,570 | +108.4% | 0.00% | – |
| Q1 2014 | $1,562,000 | -9.0% | 371,157 | -0.5% | 0.00% | – |
| Q4 2013 | $1,716,000 | -64.3% | 372,915 | -51.9% | 0.00% | -100.0% |
| Q3 2013 | $4,806,000 | +124.0% | 775,460 | +96.5% | 0.00% | 0.0% |
| Q2 2013 | $2,146,000 | – | 394,614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
| ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
| Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
| Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
| NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
| Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
| Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
| First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
| DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
| RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |